Livio Gagliardi, Intermedical’s Administrative Director explains how two 5 litre oxygen concentrators can be daisy chained to produce 10 litres of medical grade oxygen.
At the time of writing, India’s battle with COVID-19 has reached its deadliest since the pandemic began. Peaking at 4000 deaths a day and a healthcare system on the brink of collapse, citizens in the country are resorting to the international community for help. In recent weeks, low oxygen supplies and in some cases hospitals completely running out have exacerbated the issue prompting a surge in demand oxygen concentrators.
Since the beginning of the 2nd wave in India, Intermedical have responded to calls for help working closely with a number of charities, private organisations and individuals
The team at Intermedical have worked tirelessly to source stock and have been working around the clock to test and pack every single device. Today, we are proud to announce that over 2000 oxygen concentrators have left our warehouse bound for India.
We are pleased that we’ve been able to play a small part in supporting the international efforts for India’s COVID emergency.
Since the beginning of the Coronavirus pandemic, we have learnt a lot about how it affects the human body and health in general. COVID-19 is a viral infection that attacks the respiratory system with the potential to cause viral pneumonia.
A pulse oximeter is a cheap, simple yet effective way to monitor lung health. For patients who have tested positive for COVID may want to monitor their lung health and this can be done using a pulse oximeter.
It’s a non-invasive test that typically involves a small unit or sensor to wrap around a finger to measure the oxygen saturation in blood and pulse rate.
Oxygen saturation is measured in %SpO2. In a healthy subject, %SpO2 is expected to be anywhere between 95 to 99%, even at exertion. When levels drop below 90%, it is vital to be assessed without delay. The nature of the virus hinders the normal operation of our lungs that transfers oxygen to red blood stream. This in turn deprives vital organs of the oxygen it needs and if left untreated may result in death.
At the time of writing there is currently no cure although new treatments and drugs have emerged over time in a bid to reduce mortality rate. A vaccine produced by Oxford University as well as a few other candidates globally are currently going through last phases of clinical trials and are expected to role out as early as December.
A recent media briefing by WHO’s Director General has cited the huge demand for supplementary Oxygen as cases continue to grow at an exponential rate across the globe.
One of the most effective ways of saving lives is providing oxygen to patients who need it.
Since the beginning of the pandemic, Oxygen therapy has played a vital role in treating patients with severe and critical COVID-19.
“This has been an area of intense focus for WHO since the beginning of the pandemic.
Patients with severe and critical COVID-19 cannot get enough oxygen into their blood by breathing normally. They need higher concentrations of oxygen and support to get it into their lungs.”
The majority of positive COVID-19 cases have reported mild to no symptoms at all. Patients with severe symptoms that are left untreated can deprive cells and organs of the oxygen they need, which ultimately leads to organ failure and death.
With hospitals reaching capacity, the demand for Oxygen is outstripping supply with some reporting they are “running out”.
Countries across the world are experiencing difficulties in obtaining oxygen concentrators.
Medical oxygen is produced using oxygen concentrators, which extract and purify oxygen from the air. According to the WHO, it is estimated that at 1 million new cases a week, the world needs about 620,000 cubic meters of oxygen a day. This was reported in June. With the second wave of the virus now taking its toll, its inevitable that this number and demand for Oxygen concentrators will be higher.
Since the first wave of the pandemic, Intermedical have played a vital role in supporting our NHS as well as private patients with their Oxygen needs.
We are ready and fully stocked to accommodate an expected surge in demand as the second wave continues to grow across the UK.
Dr Simon Barry, A respiratory clinical lead in Wales has suggested that “Oxygen levels in suspected coronavirus cases should be monitored in the community to help hospitals cope with a second wave of cases.”
Speaking to BBC NEWS in June, Dr Barry said early on in the pandemic it became clear reduced oxygen levels in the blood suggested a patient had Covid-19.
With flu and pneumonia set to add more pressure to the NHS as the winter sets in, it is suggested that more community monitoring would be needed in order to ease the pressure.
For the majority, people with coronavirus show mild symptoms, and sometimes none at all.
But more commonly, those who display low blood oxygen saturation levels are admitted to hospital with Coronvirus.
In healthy adults, saturation levels are expected to be between 94% and 99%, whereas those with Covid-19 can fall below 90% and require oxygen therapy and, in some cases, ventilation in intensive care.
Intermedical is the UK’s leading private respiratory care company that distributes oxygen therapy and monitoring equipment to the NHS as well as private individuals. Since the beginning of the pandemic, we have supported thousands of people providing essential and life-saving equipment for home nursing of the virus.
To see our range of Home Oxygen Concentrators, CLICK HERE
To monitor your oxygen levels, you can purchase one of our pulse oximeters HERE
Ref: BBC NEWS – https://www.bbc.co.uk/news/uk-wales-53136289
In response to the COVID-19 pandemic, more than 10,000 items of critical medical equipment have been made available to the NHS frontline including oxygen concentrators provided by Intermedical.
This huge logistical operation spanned across three months reaching the operations final milestone on Tuesday 30th June. It involved the MOD’s procurement arm Defence Equipment & Support (DE&S) working closely with Team Leidos (the MOD Delivery Partner) as well as the Department for Health and Social Care, NHS, Cabinet Office and PA Consultants.
Defence Minister Jeremy Quin said:
“I am proud of our dedicated logistics and delivery professionals who have made a significant contribution to the COVID 19 pandemic response. They have delivered a huge quantity of medical supplies right across the UK, ensuring our frontline NHS staff have the equipment they need to provide life-saving medical care.
Their professionalism and enthusiasm maintained the flow of critical equipment ever since this national endeavour to support the UK Government’s response to COVID-19 started on March 30.”
Intermedical is the UK’s leading provider of portable and home oxygen therapy equipment. In response to the COVID-19 pandemic, we have provided home oxygen concentrators to thousands of users across the UK to aid home nursing of the virus.
See our range of OXYGEN CONCENTRATORS HERE
Prime Minister Boris Johnson has detailed his experience with COVID-19 saying he needed ‘litres and litres’ of oxygen in his first interview since his recovery.
Since leaving hospital, the Prime Minister has said he was a “very lucky man” and praised the staff at St Thomas’ Hospital in London.
He was first diagnosed with Covid-19 in late March, spending more than ten days in self-isolation before being moved to St Thomas’ Hospital, where his condition initially worsened.
Oxygen therapy again has played a vital part in the treatment of COVID.
The majority of cases display mild to no symptoms at all with the most vulnerable being patients in older age groups and those with underlying conditions.
Pulse oximeters and home medical oxygen concentrators can help monitor and help provide vital therapy for patients with COVID and are available for sale to the public by clicking this link here.
Unless you’ve been living on a remote island somewhere you will know that COVID-19 otherwise known as Coronavirus, has been wreaking havoc across the globe in recent months. At the time of writing, over 100,000 people across all major continents have had or suffering from the virus. And whilst governments all over the world are “doing all they can” to contain it, the virus is spreading at an alarming rate.
This new strain of Coronavirus hasn’t been seen before in humans with the most common symptoms being headache, fever, fatique, dry cough, sore throat and muscle aches. 31% of cases have also reported shortness of breath.
COVID-19 attacks the tissues and airways deep inside the lungs. The disease can progress to viral pneumonia which is a real worry for those already suffering from an immune deficiency or a respiratory ailment such as COPD or Asthma. It can cause inflammation of the lungs effecting the alveoli and the transfer of oxygen to red blood cells.
In the case of this new Coronavirus, viral pneumonia can’t be treated with antibiotics – and any antiviral drugs used to combat flu would also be ineffective, for the moment at least.
A recent publication by the World Health Organisation mentions that “Oxygen therapy is the major treatment intervention for patients with severe COVID-19”
As pneumonia hinders the transfer of Oxygen into our bloodstream, for those who are particularly vulnerable, using an oxygen concentrator can support lung function by keeping red blood cells saturated as best it can until the infection passes.
Intermedical homecare are excited to introduce the brand new INOGENONE G5 portable oxygen concentrator in the UK. This brand new addition to our range takes portable oxygen therapy to a whole new level.
Weighing just 4.7lbs, the INOGENONE G5 is our 2nd most compact POC in our range. In addition, it offers an incredible 6 pulse flow settings – the only truly portable device in our range (and the world) to offer such a capacity. making portable oxygen therapy more accessible even for those who have higher demands
INOGEN have done it again! This time they have really set the bar high with this incredible new feat of medical engineering. The G5 portable oxygen concentrator is expected to land towards the end of 2019 and no doubt will be a highly sought after device.
Offering 6 pulse flow settings and weighing just 4.7lbs, the INOGENONE G5 makes it all possible – Making portable oxygen therapy more accessible for an even wider range of oxygen users – even for those who require a more demanding level of oxygen whilst on the go.
The design closely resembles that of the smaller G4 model standing approximately 8 inches in height and 7 inches in width, and comes with a single (up to 6.5 hours runtime) or double battery (up to 13 hours).
To learn more, why not register your interest by contacting us here or call 0845 862 9500